The Subject Expert Committee is having an important meeting today regarding the Corona vaccine. It considered giving emergency approval to Kovishield, the Corona vaccine of Oxford AstraZeneca. After which the emergency use of the Covishield vaccine being made by the Serum Institute was approved. However, according to the government’s top sources, Covishield of Serum Institute of India (SII) has received a recommendation from the panel for approval. But the final decision on this is yet to be taken by DCGI.
Dry run in UP tomorrow
Talking about tomorrow’s dry run in Uttar Pradesh, the state’s chief health secretary Amit Mohan Prasad said, “We will do a dry run of the Kovid vaccine tomorrow at 6 centres including Sahara Hospital, RML Hospital, KGMU and SGPGI in Lucknow.
5 districts of Jharkhand will have a dry run
On January 2, a dry run of corona vaccination is to be held in five districts of Jharkhand – Kanchi, East Singhbhum, Chatra, Palamu and Pakur. Giving this information, the state Health Minister Banna Gupta said that all the necessary preparations have been completed. 7000 health workers have been trained for the vaccination campaign.
A vaccine to be given to 30 crore people
300 million people will be given the first vaccine on a priority basis. There is a solid preparation behind these steely intentions of PM Narendra Modi. India has now reached its campaign about the vaccine. Tell you how the vaccine is in India
– Oxford and AstraZeneca’s Covishlid is ready.
– India biotech and ICMR vaccine are also ready.
Vaccine Covishield of Serum Institute of India, the world’s largest vaccine-producing company, has been granted clutch use in India. The decision on this has been taken by a special panel made by the Drug Controller of India. An Expert Committee on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) is set to make a recommendation to approve the emergency use of Kovishield, an anti-Corona virus vaccine in Oxford.
In Britain, this vaccine was believed to be allowed in India after getting emergency use permission. The Serum Institute is a partner in Oxford’s vaccine and will sell the vaccine in the country under the name Covishield.